Trial Information
Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
Inclusion Criteria:
- Post-menopausal woman without superior age limit
- No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone
receptor positive, treated by conservative surgery or total mastectomy and requiring
additive treatment by radiotherapy and hormonotherapy
- The patients including in another clinical trial can be include in this observatory
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
radiation side effects
Outcome Description:
Describe, in real situation, the ionisant radiation effects on the healthy tissues in patients receiving anastrazole in association or sequential with radiotherapy
Outcome Time Frame:
5 years after the end of radiotherapy
Safety Issue:
Yes
Principal Investigator
Yazid BELKACEMI, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Centre Oscar Lambret
Authority:
France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
Study ID:
ORACLES
NCT ID:
NCT01183832
Start Date:
August 2005
Completion Date:
August 2014
Related Keywords:
- Breast Cancer
- Breast cancer
- radiotherapy
- hormonotherapy
- Breast Neoplasms